Department of Toxicology, College of Pharmacy, Chungnam National University, Yuseong-Gu, Daejeon, South Korea.
FEBS Lett. 2011 Jan 21;585(2):421-8. doi: 10.1016/j.febslet.2010.12.030. Epub 2010 Dec 25.
The overexpression of metallothionein-2A (MT-2A) is frequently observed in invasive human breast tumors and has been linked with more aggressive breast cancers. MT-2A overexpression led to the induction of MDA-MB-231 breast cancer cell migratory and invasive abilities. The reduction of MT-2A expression through small interfering RNA (siRNA) targeting MT-2A in invasive MDA-MB-231 cells completely inhibited both cell invasion and migration. In addition, the expression of matrix metalloproteinase-9 (MMP-9) and the transcriptional activity of AP-1 and NF-κB were upregulated by MT-2A overexpression. Collectively, our results provide the first demonstration that MT-2A promotes breast cancer cell invasion by upregulating MMP-9 via AP-1 and NF-κB activation. Furthermore, we found that MT-2A silencing can inhibit breast cancer invasiveness.
金属硫蛋白-2A(MT-2A)的过度表达在侵袭性人类乳腺癌中经常观察到,并与更具侵袭性的乳腺癌相关。MT-2A 的过度表达导致 MDA-MB-231 乳腺癌细胞迁移和侵袭能力的诱导。通过针对侵袭性 MDA-MB-231 细胞中的 MT-2A 的小干扰 RNA(siRNA)降低 MT-2A 的表达完全抑制了细胞侵袭和迁移。此外,基质金属蛋白酶-9(MMP-9)的表达和 AP-1 和 NF-κB 的转录活性被 MT-2A 的过度表达上调。总之,我们的结果首次证明 MT-2A 通过激活 AP-1 和 NF-κB 来上调 MMP-9 促进乳腺癌细胞的侵袭。此外,我们发现 MT-2A 沉默可以抑制乳腺癌的侵袭性。